Jānis Blumfelds
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jānis Blumfelds has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Alexander Rosendahl
Institute of Family Medicine and Public Health, University of Tartu
1 shared publicationAnet Vanaveski
Family Medicine Residency, University of Tartu
1 shared publication- Aurimas Rapalavičius
Department of Family Medicine, Lithuanian University of Health Sciences
1 shared publication - Hans Thulesius
Center for Primary Health Care Research, Department of Clinical Sciences Malmö, Lund University, Jan Waldenströms gata 35, Malmö, 20213, Sweden, 46 0767700240
1 shared publication - Liina Pilv-Toom
Institute of Family Medicine and Public Health, University of Tartu
1 shared publication - Mette Brekke
Department of General Practice, Institute of Health and Society, University of Oslo
1 shared publication
Latest Publications
- Open Access
- 21 January 2025
- Published by Taylor & Francis in Scandinavian Journal of Primary Health Care
- Vol. 43 (2) , 403-410
General practitioners’ clinical decision-making in patients that could have cancer: a vignette study comparing the Baltic states with four Nordic countries
Relative one-year cancer survival rates in the Baltic states are lower than the European mean; in the Nordic countries they are higher than the mean. This study investigated the likelihood of General Practitioners (GPs) investigating or referring patients with a low but significant risk of cancer in these two regions, and how this was affected by GP demographics. A survey of GPs using clinical vignettes. General Practice in Denmark, Estonia, Finland, Latvia, Lithuania, Norway, and Sweden. General Practitioners. A regional comparison of GPs' stated immediate diagnostic actions (whether or not they would perform a key diagnostic test and/or refer to a specialist) for patients with a low but significant risk of cancer (between 1.2 and 3.6%). Of the 427 GPs that completed the questionnaire, those in the Baltic states, and GPs that were more experienced, were more likely to arrange a key diagnostic test and/or refer their patient to a specialist than those in Nordic Countries or who were less experienced (p < 0.001 for both measures). Neither GP sex nor practice location within a country showed a significant association with these measures. While relative one-year cancer survival rates are lower in the Baltic states than in four Nordic countries, we found no evidence that this is due to their GPs' reluctance to take immediate diagnostic action, as GPs in the Baltic states were more likely to investigate and/or refer at the first consultation. Research on patient and secondary care factors is needed to explain the survival differences.
- 21 January 2025
- Published by Taylor & Francis in Scandinavian Journal of Primary Health Care
- Vol. 43 (2) , 403-410
Open AccessGeneral practitioners’ clinical decision-making in patients that could have cancer: a vignette study comparing the Baltic states with four Nordic countries
Relative one-year cancer survival rates in the Baltic states are lower than the European mean; in the Nordic countries they are higher than the mean. This study investigated the likelihood of General Practitioners (GPs) investigating or referring patients with a low but significant risk of cancer in these two regions, and how this was affected by GP demographics. A survey of GPs using clinical vignettes. General Practice in Denmark, Estonia, Finland, Latvia, Lithuania, Norway, and Sweden. General Practitioners. A regional comparison of GPs' stated immediate diagnostic actions (whether or not they would perform a key diagnostic test and/or refer to a specialist) for patients with a low but significant risk of cancer (between 1.2 and 3.6%). Of the 427 GPs that completed the questionnaire, those in the Baltic states, and GPs that were more experienced, were more likely to arrange a key diagnostic test and/or refer their patient to a specialist than those in Nordic Countries or who were less experienced (p < 0.001 for both measures). Neither GP sex nor practice location within a country showed a significant association with these measures. While relative one-year cancer survival rates are lower in the Baltic states than in four Nordic countries, we found no evidence that this is due to their GPs' reluctance to take immediate diagnostic action, as GPs in the Baltic states were more likely to investigate and/or refer at the first consultation. Research on patient and secondary care factors is needed to explain the survival differences.